Document is current
Any future updates will be listed below
-
Authors
von Dadelszen, Peter http://orcid.org/0000-0003-4136-3070
Audibert, François
Bujold, Emmanuel
Bone, Jeffrey N.
Sandhu, Ash
Li, Jing
Kariya, Chirag
Chung, Youkee
Lee, Tang
Au, Kelvin
Skoll, M. Amanda
Vidler, Marianne
Magee, Laura A.
Piedboeuf, Bruno
Baker, Philip N.
Lalji, Sayrin
Lim, Kenneth I.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02442492 at ClinicalTrials.govDocuments that mention this clinical trial
Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations
https://doi.org/10.1186/s13104-022-06107-y
-
Funding
Funding for this research was provided by:
CIHR (MOP-137077)
- License Information
-
More Information
Article History
Received: 1 February 2022
Accepted: 13 June 2022
First Online: 7 July 2022
Declarations
:
: The study protocol was approved by the UBC Children's and Women's Research Ethics Board (REB) (H15-00899) and received a No Objection Letter (NOL) from Health Canada (NOL number: HC6-24-C1864589). All participants read and signed an approved informed consent form prior to PLGF measurement and randomisation.
: N/A
: PvD has received support from Alere International.
